S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Stock market today: European shares gain and Asian shares are mixed, with Chinese markets on holiday
Nursing Home REITs: The Surprise Heroes of High Yield Investing
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
Billionaire Ryan Cohen takes over as CEO at GameStop, adding to chairman role
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Liverpool owner FSG announces minority investment by New York equity firm
3 Reasons Micron is a Buy on Market Weakness
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Stock market today: European shares gain and Asian shares are mixed, with Chinese markets on holiday
Nursing Home REITs: The Surprise Heroes of High Yield Investing
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
Billionaire Ryan Cohen takes over as CEO at GameStop, adding to chairman role
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Liverpool owner FSG announces minority investment by New York equity firm
3 Reasons Micron is a Buy on Market Weakness
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Stock market today: European shares gain and Asian shares are mixed, with Chinese markets on holiday
Nursing Home REITs: The Surprise Heroes of High Yield Investing
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
Billionaire Ryan Cohen takes over as CEO at GameStop, adding to chairman role
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Liverpool owner FSG announces minority investment by New York equity firm
3 Reasons Micron is a Buy on Market Weakness
S&P 500   4,299.70
DOW   33,666.34
QQQ   358.01
Can Undervalued Healthcare Stocks Add Yield To Your Portfolio?
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Stock market today: European shares gain and Asian shares are mixed, with Chinese markets on holiday
Nursing Home REITs: The Surprise Heroes of High Yield Investing
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Energy Stocks Shine as High Oil Prices Boost Dividend Yields
Billionaire Ryan Cohen takes over as CEO at GameStop, adding to chairman role
U.S. drive to onshore battery supply chains could create big winners in lithium (Ad)
Liverpool owner FSG announces minority investment by New York equity firm
3 Reasons Micron is a Buy on Market Weakness

Absci (ABSI) Stock Forecast, Price & News

$1.38
+0.03 (+2.22%)
(As of 09/28/2023 ET)
Compare
Today's Range
$1.29
$1.38
50-Day Range
$1.28
$2.41
52-Week Range
$1.13
$3.71
Volume
192,923 shs
Average Volume
527,154 shs
Market Capitalization
$127.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00

Absci MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
407.2% Upside
$7.00 Price Target
Short Interest
Bearish
3.80% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.97) to ($0.76) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.04 out of 5 stars

Medical Sector

624th out of 970 stocks

Commercial Physical Research Industry

11th out of 14 stocks


ABSI stock logo

About Absci (NASDAQ:ABSI) Stock

Absci Corporation operates as a generative AI drug creation company in the United States. Its integrated drug creation platform identifies novel drug targets and creates biotherapeutic candidates. The company was founded in 2011 and is headquartered in Vancouver, Washington.

ABSI Price History

ABSI Stock News Headlines

Absci (NASDAQ:ABSI) Stock Price Up 0.6%
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Absci to Host R&D Day on October 4, 2023
U.S. drive to onshore battery supply chains could create big winners in lithium
Investor Find Lithium Gold and Crush the Bear Market with 32k Metric Tons
Absci (NASDAQ: ABSI)
H.C. Wainwright Reaffirms Their Buy Rating on AbSci (ABSI)
See More Headlines
Receive ABSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Absci and its competitors with MarketBeat's FREE daily newsletter.

ABSI Company Calendar

Last Earnings
8/14/2023
Today
9/28/2023
Next Earnings (Estimated)
11/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ABSI
Fax
N/A
Employees
193
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$7.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+407.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-104,900,000.00
Net Margins
-1,305.27%
Pretax Margin
-1,314.54%

Debt

Sales & Book Value

Annual Sales
$5.75 million
Book Value
$2.97 per share

Miscellaneous

Free Float
81,975,000
Market Cap
$127.94 million
Optionable
Not Optionable
Beta
1.23
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Sean McClainMr. Sean McClain (Age 33)
    Founder, CEO, Pres & Director
    Comp: $936.2k
  • Dr. Zachariah Jonasson Ph.D. (Age 50)
    Chief Bus. Officer, CFO & Director
    Comp: $98.3k
  • Dr. Sarah Korman J.D. (Age 43)
    Ph.D., Chief Legal Officer & Corp. Sec.
    Comp: $575.58k
  • Dr. Andreas Busch Ph.D. (Age 60)
    Chief Innovation Officer
    Comp: $1.56M
  • Mr. Todd Bedrick CPAMr. Todd Bedrick CPA
    Sr. VP & Chief Accounting Officer
  • Mr. Alexander Khan CPA
    VP of Fin. & Head of Investor Relations
  • Mr. Jack Gold
    Chief Marketing Officer
  • Karin Wierinck
    Chief People Officer
  • Melissa Patterson Ph.D.
    Chief of Staff
  • Jens Plassmeier Ph.D.
    Sr. VP of Synthetic Biology R&D













ABSI Stock - Frequently Asked Questions

Should I buy or sell Absci stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Absci in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ABSI shares.
View ABSI analyst ratings
or view top-rated stocks.

What is Absci's stock price forecast for 2023?

2 Wall Street analysts have issued 12-month target prices for Absci's stock. Their ABSI share price forecasts range from $4.00 to $10.00. On average, they anticipate the company's share price to reach $7.00 in the next year. This suggests a possible upside of 407.2% from the stock's current price.
View analysts price targets for ABSI
or view top-rated stocks among Wall Street analysts.

How have ABSI shares performed in 2023?

Absci's stock was trading at $2.10 at the beginning of 2023. Since then, ABSI shares have decreased by 34.3% and is now trading at $1.38.
View the best growth stocks for 2023 here
.

When is Absci's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 8th 2023.
View our ABSI earnings forecast
.

How were Absci's earnings last quarter?

Absci Co. (NASDAQ:ABSI) announced its earnings results on Monday, August, 14th. The company reported ($0.27) earnings per share for the quarter, missing the consensus estimate of ($0.24) by $0.03. The business had revenue of $3.37 million for the quarter, compared to analyst estimates of $2.59 million. Absci had a negative trailing twelve-month return on equity of 36.62% and a negative net margin of 1,305.27%.

When did Absci IPO?

(ABSI) raised $200 million in an IPO on Thursday, July 22nd 2021. The company issued 12,500,000 shares at $15.00-$17.00 per share.

What is Absci's stock symbol?

Absci trades on the NASDAQ under the ticker symbol "ABSI."

Who are Absci's major shareholders?

Absci's stock is owned by a number of retail and institutional investors. Top institutional investors include Casdin Capital LLC (1.48%), Platinum Investment Management Ltd. (1.41%), BlackRock Inc. (1.34%), Farther Finance Advisors LLC (0.49%), Geode Capital Management LLC (0.49%) and Renaissance Technologies LLC (0.46%). Insiders that own company stock include Karen K Mcginnis, Sarah Korman, Sean Mcclain and Todd Bedrick.
View institutional ownership trends
.

How do I buy shares of Absci?

Shares of ABSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Absci's stock price today?

One share of ABSI stock can currently be purchased for approximately $1.38.

How much money does Absci make?

Absci (NASDAQ:ABSI) has a market capitalization of $127.94 million and generates $5.75 million in revenue each year. The company earns $-104,900,000.00 in net income (profit) each year or ($1.22) on an earnings per share basis.

How many employees does Absci have?

The company employs 193 workers across the globe.

How can I contact Absci?

The official website for the company is www.absci.com. The company can be reached via phone at 360-949-1041 or via email at investors@absci.com.

This page (NASDAQ:ABSI) was last updated on 9/29/2023 by MarketBeat.com Staff

My Account -